Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01058421 · ClinicalTrials.gov registry record · NA

Treatment of Critical Illness Polyneuromyopathy

A NA study of Acute Respiratory Failure, sponsored by University of Colorado, Denver.

Completed
Registry status
NA
Development phase
120
Enrollment target
5
Study locations

NCT01058421: Completed NA study of Acute Respiratory Failure, sponsored by University of Colorado, Denver.

NCT01058421 is a NA study of Acute Respiratory Failure that has completed, run by University of Colorado, Denver. The registered enrollment target is 120 participants, below the 1,472-participant average among 13 other Acute Respiratory Failure trials with a reported enrollment target (92% lower). The trial reports 5 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01058421, a NA study of Acute Respiratory Failure, has completed, sponsored by University of Colorado, Denver.

COMPLETED
Registry status
NA
Development phase
120 participants
Enrollment target
5
Study locations

Study Summary

Acute respiratory failure is a heterogeneous disorder that results in more than 300,000 Americans requiring admission to an intensive care unit for invasive mechanical ventilatory support each year. Though acute respiratory failure is a pulmonary disorder, patients who survive their hospitalization are not limited by respiratory symptoms after discharge. Rather persistent neuromuscular weakness is the primary disorder that adversely alters their quality of life and ability to function on a daily basis. In this application the investigators plan to conduct a randomized clinical trial called the Do It Now study (Diagnosis and Treatment of Neuromuscular Weakness) to determine the effectiveness of an intensive physical therapy program for patients recovering from acute respiratory failure. This trial will establish the efficacy of the physical therapy programs that is currently performed for patients with acute respiratory failure in a non-evidence based manner across the United States.

Primary Outcome

The CS-PFP-10 provides an overall score and scores for upper body strength, upper body flexibility, lower body strength, balance and coordination, and endurance. The test is used to assess an individual's overall capacity to carry out activities of daily living by measuring and quantifying 10 typical activities including sweeping a floor, transferring clothes from a washer to a dryer, and carrying groceries. Tasks are quantified using time alone, time and weight, and distance. This test provides

Conditions Studied

Interventions

  • PROCEDURE intensive physical therapy
  • PROCEDURE control group

Study Locations (5)

Colorado

  • Medical Center of Aurora - Aurora
  • University of Colorado Denver - Aurora
  • Rose Medical Center - Denver
  • Swedish Medical Center - Englewood
  • St. Anthony Hospital - Lakewood

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2009-09
Est. Completion 2015-10
Phase NA
University of Colorado, Denver

1,283 total trials

What the finished NCT01058421 record still lists

NCT01058421 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,472-participant average among 13 other Acute Respiratory Failure trials with a reported enrollment target (92% lower).

The record links to 1 condition, with Acute Respiratory Failure appearing as the primary indexed condition, and to 2 interventions - of which intensive physical therapy is the first listed.

NCT01058421 lists 5 locations in 1 state (Colorado).

Frequently Asked Questions

What is clinical trial NCT01058421 about?

NCT01058421 is a clinical study titled "Treatment of Critical Illness Polyneuromyopathy". Acute respiratory failure is a heterogeneous disorder that results in more than 300,000 Americans requiring admission to an intensive care unit for invasive mechanical ventilatory support each year. Though acute respiratory failure is a pulmonary disorder, patients who survive their hospitalization ...

What is the current status of trial NCT01058421?

This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2009-09. Estimated completion is 2015-10.

What conditions does trial NCT01058421 study?

This clinical trial studies the following conditions: Acute Respiratory Failure.

What interventions are being tested in trial NCT01058421?

The interventions under investigation include: intensive physical therapy (PROCEDURE), control group (PROCEDURE).

Who is sponsoring clinical trial NCT01058421?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01058421 being conducted?

This trial has 5 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acute Respiratory Failure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01058421's enrollment target sits among peer trials

120 9th of 13 higher than 5 of 13 other Acute Respiratory Failure trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Acute Respiratory Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01174108 · 120 participants · Phase 2

    Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

  • NCT01627301 · 120 participants · NA

    Sympathetic Overactivity in Post-traumatic Stress Disorder

  • NCT02025023 · 120 participants · Phase 3

    Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study

  • NCT02128906 · 120 participants · Phase 2

    Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01058421, the US trial registry maintained by the National Library of Medicine. NCT01058421 (mid enrollment · multi site footprint · completed) retrieved and formatted by PlainTrial, see methodology.